EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden
Status:
Recruiting
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
Patients with multiple colorectal liver metastases that progress on 1st line chemotherapy
have a very dismal prognosis, and their options are few. Resections are regularly performed
although this is only supported by anecdotal evidence for this patient group. We want to
assess whether resections actually confer benefit as compared to 2nd line chemotherapy alone,
in a randomized controlled trial.